TCL Archive High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer January 25, 2008
TCL Archive FTE Shortage Hurting Cancer and AIDS Research, Advisors Told; NCI Seeks Major Share Of New Slots October 14, 1988
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
